Biology of Submucosal Gland Stem Cells in the Airway

气道粘膜下腺干细胞的生物学

基本信息

  • 批准号:
    10649543
  • 负责人:
  • 金额:
    $ 70.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-20 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Project Summary Airway submucosal glands (SMGs) are known to contain reserve stem cells for the surface airway epithelium (SAE). In mice, this niche serves only the trachea; however, in larger mammals such as humans, pigs and ferrets, SMGs are present throughout the intralobar cartilaginous airways and may serve the broader function of maintaining the proximal conducting airway epithelium in the setting of disease. During the previous six funding cycles, this grant has used mouse and ferret genetic models to address multiple aspects of airway SMG biology, SMG stem/progenitor cell biology, and cystic fibrosis (CF) lung pathogenesis. This proposal aims to identify the subpopulations of glandular myoepithelial cells (GMECs) that participate in airway repair, as well as the Wnt- regulated mechanisms that control their behavior following injury. Based on our preliminary data, we hypothesize that Lef-1 and Sox9 transcription factors differentially control Wnt-responsive GMEC states that orchestrate the commitment, renewal, migration, and proliferative expansion of GMECs on the airway surface. Aim 1 will define the biology of tracheal GMECs in mice and utilize an array of transgenic lines (intersectional lineage tracing, conditional knockout, Wnt-reporters, Dox-inducible H2B-GFP) to study the involvement of Lef-1 and Sox9 in regulating processes that control GMEC commitment, renewal, migration, and proliferation. Aim 2 will use intersectional lineage tracing in ferrets to define the participation of GMEC subtypes and gland ductal cells in maintaining the extralobar and intralobar SAE at homeostasis and following injury. We hypothesize that gland ducts are a site for GMEC maturation to a pre-basal cell state, and that this underlying hierarchical relationship is disturbed in chronic airway diseases such as CF. Aim 3 will test this hypothesis by identifying disturbances in GMEC and gland duct niches in the setting of mild and severe CF lung disease, using VX-770-responsive CFTRG551D ferrets. Novel aspects of these studies include the first non-rodent fate mapping in a species (ferret) that closely models CF lung disease and SMG biology of humans, and supporting fate mapping data demonstrating that ferret GMECs (ACTA2CreER) and gland ductal cells (KRT7CreER) participate in SAE repair. This research will also shed light on differences in the behavior of SMG stem cell compartments in the extralobar and intralobar cartilaginous airways, which cannot be addressed in mice because they lack SMGs in the intralobar airways. This project is designed to enhance our understanding of stem cell phenotypes in airway SMGs and the mechanisms that regulate their participation in SMG and surface airway repair. Given that GMECs can regenerate both glandular and surface airway cell types, they are an attractive target for gene editing in CF and such efforts will be enhanced by knowledge gained from this proposal. Furthermore, this work will delineate disease-associated changes to SMG stem cell niches that may be important for the pathogenesis of CF airway disease and other hypersecretory diseases that affect SMGs, such as asthma and chronic bronchitis.
项目概要 已知气道粘膜下腺 (SMG) 含有气道表面上皮的储备干细胞 (美国汽车工程师学会)。在小鼠中,这个生态位只服务于气管;然而,在人类、猪和雪貂等大型哺乳动物中, SMG 存在于整个叶内软骨气道中,并且可以发挥更广泛的功能 在疾病情况下维持近端传导气道上皮。在前六次融资期间 周期,这笔赠款使用小鼠和雪貂遗传模型来解决气道 SMG 生物学的多个方面, SMG 干/祖细胞生物学和囊性纤维化 (CF) 肺发病机制。该提案旨在确定 参与气道修复的腺肌上皮细胞 (GMEC) 亚群以及 Wnt- 控制他们受伤后行为的调节机制。根据我们的初步数据,我们假设 Lef-1 和 Sox9 转录因子差异性地控制 Wnt 响应的 GMEC 状态,从而协调 气道表面 GMEC 的承诺、更新、迁移和增殖扩张。目标 1 将定义 小鼠气管 GMEC 的生物学,并利用一系列转基因系(交叉谱系追踪、 条件敲除、Wnt 报告基因、Dox 诱导的 H2B-GFP)来研究 Lef-1 和 Sox9 在 监管控制 GMEC 承诺、更新、迁移和扩散的流程。目标2将使用 雪貂中的交叉谱系追踪以确定 GMEC 亚型和腺导管细胞的参与 维持叶外和叶内 SAE 的稳态以及受伤后的状态。我们假设腺体 导管是 GMEC 成熟到前基底细胞状态的场所,并且这种潜在的层次关系 慢性气道疾病(如 CF)会受到干扰。目标 3 将通过识别干扰来检验这一假设 使用 VX-770 响应在轻度和重度 CF 肺部疾病中的 GMEC 和腺管生态位 CFTRG551D 雪貂。这些研究的新颖之处包括第一个物种(雪貂)的非啮齿动物命运图谱 密切模拟人类 CF 肺病和 SMG 生物学,并支持命运图谱数据 证明雪貂 GMEC (ACTA2CreER) 和腺导管细胞 (KRT7CreER) 参与 SAE 修复。这 研究还将揭示叶外和叶外 SMG 干细胞区室行为的差异。 叶内软骨气道,无法在小鼠中解决,因为它们在叶内缺乏 SMG 航空公司。该项目旨在增强我们对气道 SMG 中干细胞表型的理解, 调节其参与 SMG 和表面气道修复的机制。鉴于 GMEC 可以 再生腺体和表面气道细胞类型,它们是 CF 和 中基因编辑的有吸引力的目标 从该提案中获得的知识将加强此类努力。此外,这项工作将描绘 SMG 干细胞生态位的疾病相关变化可能对 CF 气道的发病机制很重要 疾病和其他影响 SMG 的分泌过多疾病,例如哮喘和慢性支气管炎。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN F ENGELHARDT其他文献

JOHN F ENGELHARDT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN F ENGELHARDT', 18)}}的其他基金

Biology of Submucosal Gland Stem Cells in the Airway
气道粘膜下腺干细胞的生物学
  • 批准号:
    10516449
  • 财政年份:
    2022
  • 资助金额:
    $ 70.18万
  • 项目类别:
National Ferret Research and Resource Institute (NFRRI) at University of Iowa
爱荷华大学国家雪貂研究与资源研究所 (NFRRI)
  • 批准号:
    10596901
  • 财政年份:
    2022
  • 资助金额:
    $ 70.18万
  • 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
  • 批准号:
    10599931
  • 财政年份:
    2021
  • 资助金额:
    $ 70.18万
  • 项目类别:
Early Pathogenesis of Cystic Fibrosis Related Diabetes
囊性纤维化相关糖尿病的早期发病机制
  • 批准号:
    10397094
  • 财政年份:
    2021
  • 资助金额:
    $ 70.18万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10470338
  • 财政年份:
    2020
  • 资助金额:
    $ 70.18万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10677622
  • 财政年份:
    2020
  • 资助金额:
    $ 70.18万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10248531
  • 财政年份:
    2020
  • 资助金额:
    $ 70.18万
  • 项目类别:
Conducting Airway Cellular Targets Required for Complementation of CF Lung Disease
传导补充 CF 肺病所需的气道细胞靶点
  • 批准号:
    10024668
  • 财政年份:
    2020
  • 资助金额:
    $ 70.18万
  • 项目类别:
National Ferret Resource and Research Center on Lung Disease
国家雪貂资源与肺部疾病研究中心
  • 批准号:
    8751112
  • 财政年份:
    2014
  • 资助金额:
    $ 70.18万
  • 项目类别:
National Ferret Resource and Research Center on Lung Disease
国家雪貂资源与肺部疾病研究中心
  • 批准号:
    9283593
  • 财政年份:
    2014
  • 资助金额:
    $ 70.18万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.18万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了